Predictive Oncology Inc. (POAI) market price of $0.92 offers the impression of an exciting value play – Invest Chronicle

Predictive Oncology Inc. (POAI) market price of $0.92 offers the impression of an exciting value play

For the readers interested in the stock health of Predictive Oncology Inc. (POAI). It is currently valued at $0.92. When the transactions were called off in the previous session, Stock hit the highs of $0.9898, after setting-off with the price of $0.97. Company’s stock value dipped to $0.9446 during the trading on the day. When the trading was stopped its value was $0.97.Recently in News on January 13, 2022, POAI Reports Strong Results From Its AI Cancer Drug Evaluation. Predictive Oncology Inc. (NASDAQ: POAI) reported the preliminary results of its Discovery 2021 program today, announcing that its Helomics subsidiary’s evaluation demonstrated their proprietary Artificial Intelligence (AI) program CoRE™ (Computational Research Engine), combined with their tumor profile data and matched ovarian cancer samples, could identify potential new chemotherapy drug uses. These drugs are not currently approved for ovarian cancer, but, with further study, could be used for ovarian cancer treatment following clinical trial and regulatory approval. You can read further details here

Predictive Oncology Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.0299 on 01/05/22, with the lowest value was $0.9150 for the same time period, recorded on 01/13/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Predictive Oncology Inc. (POAI) full year performance was 7.44%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Predictive Oncology Inc. shares are logging -60.11% during the 52-week period from high price, and 16.14% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.79 and $2.30.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2960173 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Predictive Oncology Inc. (POAI) recorded performance in the market was 1.90%, having the revenues showcasing -17.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 64.03M, as it employees total of 22 workers.

Analysts verdict on Predictive Oncology Inc. (POAI)

During the last month, 1 analysts gave the Predictive Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.1019, with a change in the price was noted -0.10. In a similar fashion, Predictive Oncology Inc. posted a movement of -10.17% for the period of last 100 days, recording 1,409,451 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for POAI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

>> 7 Top Picks for the Post-Pandemic Economy << 

Predictive Oncology Inc. (POAI): Technical Analysis

Raw Stochastic average of Predictive Oncology Inc. in the period of last 50 days is set at 17.15%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.93%. In the last 20 days, the company’s Stochastic %K was 32.76% and its Stochastic %D was recorded 37.74%.

Let’s take a glance in the erstwhile performances of Predictive Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 1.90%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -19.17%, alongside a boost of 7.44% for the period of the last 12 months. The shares increased approximately by -1.02% in the 7-day charts and went up by -1.02% in the period of the last 30 days. Common stock shares were lifted by -17.80% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Most Popular

On Key

Related Posts